Rad's Q2 2025 earnings insights, including raised guidance, Life Sciences growth, ddPCR expansion, and strategic acquisitions.

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop ...

Digital transformation is more than a buzzword; it signifies the profound shift that technology-driven change can make to the core of an organization. It involves leveraging technology to improve ...

Additionally, it has enjoyed good customer retention throughout its cloud transition and is experiencing solid annual contract value growth. However, Pegasystems has displayed inconsistencies on the ...

A major project led by Canada's Immigration Department to revamp the country's outdated asylum system and enhance the ...